About Technology Issues FAQ

Links

MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF

MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.